Clinical Trials
21 trialsNCT05195970 2026-04-17
Walnuts and Colon Health
UConn Health
Phase NA Completed
NCT04038619 2026-03-20
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT03819296 2026-03-11
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT04305145 2026-01-29
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT04407247 2025-12-23
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT06206707 2025-11-17
Immunobiome
University of Aarhus
Phase NA Recruiting
NCT06833021 2025-02-20
Screening for Hepatitis Virus B Protein X (HBx) in Colitis-associated Cancer (CAC)
IRCCS San Raffaele
Not yet recruiting
NCT04013152 2025-02-12
ROBOT CR
Institut du Cancer de Montpellier - Val d'Aurelle
Active not recruiting
NCT02600143 2024-05-06
COLIPI
University Medical Center Groningen
Completed
NCT05514561 2023-03-14
FIT and Fecal Calprotectin in Patients With Chronic Lower GI Symptoms
Mahidol University
Completed
NCT01464151 2021-08-17
Risk Factors for Colorectal Cancer in Patients With Inflammatory Bowel Disease Undergoing Surveillance: a Prospective Cohort Study
UMC Utrecht
Completed
NCT02814864 2021-08-03
PRISME
Assistance Publique - Hôpitaux de Paris
Phase 2 Unknown
NCT03601611 2020-04-21
COLAR
Herlev Hospital
Phase NA Completed
NCT02709213 2020-03-13
Determination of the Aetiologies of Acute Colitis and Early Identification of Patients Requiring Diagnostic Colonoscopy
University Hospital, Geneva
Completed
NCT03548948 2019-09-27
Obesity, Iron Regulation and Colorectal Cancer Risk
University of Illinois at Chicago
Phase NA Completed
NCT03014284 2018-09-17
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
The University of Texas Health Science Center at San Antonio
Withdrawn
NCT00518349 2018-05-29
Colonoscope Passive Bending Function
Norwegian Department of Health and Social Affairs
Phase NA Completed
NCT01369329 2016-12-07
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
Janssen Research & Development, LLC
Phase 3 Completed
NCT00533078 2015-07-23
LUNCH1
Insel Gruppe AG, University Hospital Bern
Phase 2 Completed
NCT00676832 2010-09-29
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
Prometheus Laboratories
Phase 2 Completed
NCT00237276 2007-09-24
Experience and Enhancement: Improving Colonoscopic Polyp Detection
London North West Healthcare NHS Trust
Phase NA Unknown